亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。
Cyclosporine targets PTEN-deficient cancer cells in a highly specific manner
总结
Rodney Rothstein, Ph.D.
技术优势
Offers a cancer therapeutic that is cancer-specific and minimizes damage to normal cellsOffers a therapeutics agent that specifically targets PTEN-deficient cellsUtilizes a therapeutic agent that is already used in the clinical setting Patent information:Patent (WO/2012/145426)Tech Ventures Reference: IR 2902
技术应用
Cancer treatment in PTEN-deficient cancersCancer treatment to be used in combination with other cancer therapeuticsResearch tool for studying PTEN-deficient cancers Research tool for studying CypACyclosporine is an immunosuppressive drug, currently used in transplant patients.
详细技术说明
Rodney Rothstein, Ph.D.
国家/地区
美国
欲了解更多信息，请点击 这里
